Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

被引：0

作者：

Run-Cong Nie

Xue-Bin Zou

Shu-Qiang Yuan

Ying-Bo Chen

Shi Chen

Yong-Ming Chen

Guo-Ming Chen

Xiao-Jiang Chen

Tian-Qi Luo

Shu-Man Li

Jin-Ling Duan

Yun Wang

Yuan-Fang Li

机构：

[1] Sun Yat-sen University Cancer Center,Department of Gastric Surgery

[2] State Key Laboratory of Oncology in South China,Department of Ultrasound, Sun Yat

[3] Collaborative Innovation Center for Cancer Medicine,sen University Cancer Center, State Key Laboratory of Oncology in South China

[4] Collaborative Innovation Center for Cancer Medicine,Department of Gastric Surgery, The 6th Affiliated Hospital

[5] Sun Yat-sen University,Department of Experimental Research (Cancer Institute)

[6] Sun Yat-sen University Cancer Center,Department of Hematologic Oncology, Sun Yat

[7] State Key Laboratory of Oncology in South China,sen University Cancer Center, State Key Laboratory of Oncology in South China

[8] Collaborative Innovation Center for Cancer Medicine,undefined

[9] Collaborative Innovation Center for Cancer Medicine,undefined

来源：

BMC Cancer | / 20卷

关键词：

Pancreatic cancer; Disease-free survival; Overall survival; Surrogate;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation
Fabregat Franco, Carles
Castet, Florian
La Casta, Adelaida
Adeva, Jorge
Castillo, Alfredo
Munoz, Andres
Peinado, Paloma
Martinez de Castro, Eva
Lobo, Miriam
Granja, Monica
Maria Rodriguez-Alonso, Rosa
Fernandez Montes, Ana
Vera, Ruth
Gallego, Javier
Grana, Begona
Ghanem, Ismael
Ales, Inmaculada
Molina, Raquel
Macarulla, Teresa
Aranda, Enrique
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[22] Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
Paoletti, Xavier
Oba, Koji
Bang, Yung-Jue
Bleiberg, Harry
Boku, Narikazu
Bouche, Olivier
Catalano, Paul
Fuse, Nozomu
Michiels, Stefan
Moehler, Markus
Morita, Satoshi
Ohashi, Yasuo
Ohtsu, Atsushi
Roth, Arnaud
Rougier, Philippe
Sakamoto, Junichi
Sargent, Daniel
Sasako, Mitsuru
Shitara, Kohei
Thuss-Patience, Peter
Van Cutsem, Eric
Burzykowski, Tomasz
Buyse, Marc
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21): : 1667 - 1670
[23] Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials
Ronellenfitsch, Ulrich
Jensen, Katrin
Seide, Svenja
Kieser, Meinhard
Schwarzbach, Matthias
Slanger, Tracy E.
Burmeister, Bryan
Kelsen, David
Niedzwiecki, Donna
Piessen, Guillaume
Schuhmacher, Christoph
Urba, Susan
van de Velde, Cornelis
Ychou, Marc
Hofheinz, Ralf
Lorenzen, Sylvie
EUROPEAN JOURNAL OF CANCER, 2019, 123 : 101 - 111
[24] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
Han, Kelong
Ren, Melanie
Wick, Wolfgang
Abrey, Lauren
Das, Asha
Jin, Jin
Reardon, David A.
NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
[25] Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
Saad, Everardo D.
Squifflet, Pierre
Burzykowski, Tomasz
Quinaux, Emmanuel
Delaloge, Suzette
Mavroudis, Dimitris
Perez, Edith
Piccart-Gebhart, Martine
Schneider, Bryan P.
Slamon, Dennis
Wolmark, Norman
Buyse, Marc
LANCET ONCOLOGY, 2019, 20 (03): : 361 - 370
[26] RECURRENCE-FREE SURVIVAL (RFS) AS A SURROGATE ENDPOINT (SE) FOR OVERALL SURVIVAL (OS) IN RESECTED STAGE II/III MELANOMA: A CORRELATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)
Leung, L.
Kirkwood, J.
Srinivasan, S.
Dyer, M.
Qian, A.
Pourrahmat, M. M.
Kasireddy, E.
May, J. R.
Moshyk, A.
Kurt, M.
VALUE IN HEALTH, 2023, 26 (12) : S24 - S24
[27] Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
Flaherty, Keith T.
Hennig, Michael
Lee, Sandra J.
Ascierto, Paolo A.
Dummer, Reinhard
Eggermont, Alexander M. M.
Hauschild, Axel
Kefford, Richard
Kirkwood, John M.
Long, Georgina V.
Lorigan, Paul
Mackensen, Andreas
McArthur, Grant
O'Day, Steven
Patel, Poulam M.
Robert, Caroline
Schadendorf, Dirk
LANCET ONCOLOGY, 2014, 15 (03): : 297 - 304
[28] Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
Li, Yuanfang
Yuan, Shuqiang
Chen, Yingbo
Nie, Man
Li, Jibin
Chen, Guoming
Chen, Xiaojiang
Zhang, Ruopeng
Zheng, Ziqi
Wei, Chengzhi
Zhou, Zhiwei
Nie, Runcong
Wang, Yun
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (09): : 1085 - 1091
[29] Surrogacy of Recurrence-free Survival for Overall Survival as an Endpoint of Clinical Trials of Perioperative Adjuvant Therapy in Hepatobiliary-pancreatic Cancers A Retrospective Study and Meta-analysis
Imamura, Taisuke
Ohgi, Katsuhisa
Mori, Keita
Ashida, Ryo
Yamada, Mihoko
Otsuka, Shimpei
Uesaka, Katsuhiko
Sugiura, Teiichi
ANNALS OF SURGERY, 2024, 279 (06) : 1025 - 1035
[30] Surrogate End Points for Overall Survival in Metastatic, Locally Advanced, or Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of 24 Randomized Controlled Trials
Eleftherios A. Makris
Regina MacBarb
Danielle J. Harvey
George A. Poultsides
Annals of Surgical Oncology, 2017, 24 : 2371 - 2378

← 1 2 3 4 5 →